The normalization effect of Krill Oil supplementation persisted through 48weeks during the open label extension.  Importantly, Krill Oil appeared to decrease Lupus disease activity in patients who were sicker at baseline

Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients. 

The ORKIDS clinical trial of Krill Oil supplementation for Lupus was a team effort that documented patients were uniformly omega-3 fatty acid deficient which was reversible with Krill Oil supplementation.

“Our mission is to improve human health, and since inception we have prioritized scientific investigations through R&D to understand the nutritional value and potential health benefits of Krill Oil nutrients,

The results indicate that Lupus patients have suboptimal omega-3 (measured in red blood cell membranes using the standard omega3 index) which was normalized by one month supplementation with Krill Oil. 

The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.

Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients. 

Although the researchers found no reduction in disease activity among the patients, a post-hoc sub-analysis showed a temporarily reduced disease activity among people with severe symptoms.

Today AMPEL BioSolutions, with collaborators Lupus Therapeutics and Aker Biomarine, revealed peer-reviewed results that supplementation with Omega3-rich Krill Oil improves disease activity of autoimmune Lupus patients.

The body’s immune system normally fights off infections, but the cells of an autoimmune individual are in a constant state of inflammation that specifically targets one’s own tissues like kidneys.

Cardiovascular issues such as heart attack and stroke affect Lupus patients 5-10x more often than the general population and classic risk factors do not always contribute.  Deficiency in omega-3 has been shown to contribute to increased risk of CVD.